Results 251 to 260 of about 1,653,621 (270)

EFFICACY OF MEROPENEM EXTENDED INFUSION VERSUS INTERMITTENT INFUSION IN CRITICALLY ILL PATIENTS

Critical Care Medicine, 2012
Erin Oh, Teena Abraham, Nasser Saad, Fabienne Vastey, Eric Balmir   +4 more
openaire   +1 more source

Extended infusion of β-lactams significantly reduces mortality and enhances microbiological eradication in paediatric patients: a systematic review and meta-analysis

EClinicalMedicine, 2023
Csaba Lodi, Mahmoud Obeidat, Szilvia Kiss-Dala   +2 more
exaly  

Evaluation of Meropenem Extended Versus Intermittent Infusion Dosing Protocol in Critically Ill Patients

Journal of Intensive Care Medicine, 2020
Yanina Dubrovskaya, Diana Altshuler
exaly  

Current insulin infusion set failure criteria may be too stringent for real‐life settings and may skew infusion set failure outcomes in extended‐wear infusion set studies

Diabetes, Obesity and Metabolism, 2023
Julia Mader, Jasmin Kästner
exaly  

Outcomes of extended infusion piperacillin/tazobactam for documented Gram-negative infections

Diagnostic Microbiology and Infectious Disease, 2009
Nimish Patel
exaly  

Extended infusion compared to standard infusion cefepime as empiric treatment of febrile neutropenia

Journal of Oncology Pharmacy Practice, 2018
Leanne Kennedy, John Williamson, David Cluck   +2 more
exaly  

Intermittent and extended‐infusion Beta‐Lactam utilization in cystic fibrosis

Pediatric Pulmonology, 2012
Jeffery T, Zobell, David C, Young, Barbara A, Chatfield   +2 more
openaire   +2 more sources

Piperacillin/tazobactam: extended infusion "good alternative"

Inpharma Weekly, 2007
openaire   +1 more source

Piperacillin/tazobactam: extended infusion saves costs

PharmacoEconomics & Outcomes News, 2015
openaire   +1 more source

Extended infusion of beta-lactam antibiotics: optimizing therapy in critically-ill patients in the era of antimicrobial resistance

Expert Review of Anti-Infective Therapy, 2017
Zeina Kanafani, Nesrine Rizk
exaly